Tender Details

Country: Finland
Summary: Paxlovid Drug Therapy
FIT Ref No: 93602169
Deadline: 18 Dec 2023
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: EUR 2000000
Notice Type: Tender
Document Ref. No.: 752223-2023
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The procurement unit requests offers for Paxlovid drug treatment in accordance with the request for tenders and the attached service description as well as the contract terms.
Paxlovid (nirmarelvir/ritonavir) is an oral coronavirus drug for people over 18 years of age who are at risk of developing a severe coronavirus disease,due to medication that weakens the immune system or age. The medicine should be started as soon as possible after the onset of coronavirus symptoms. Paxlovid prevents the multiplication of the coronavirus in the infected person's body. Paxlovid reduces the need for hospitalization and death in at-risk, unvaccinated adultsmanrisk. According to the latest studies, Paxlovid also significantly reduces serious illness and mortality in vaccinated people; the medication has been particularly effective in the elderly, immunocompromised and other risk groups.a work pair is estimated: from Monday to Sunday, the work input of one (1) nurse and one (1) general practitioner (medical license). The number of work pairs and the length of the work day may vary during the contract period, and the foreseeable number of people at the beginning of the contract period is two (2) work pairs.
The service includesin addition, Paxlovid drug distribution on weekends Sat-Sun.
The customer has the right to expand/reduce the service as needed by adding/reducing work pairs.
Ordering the service can also be stopped completely if there is no need for it.
One (1) service provider will be selected as the service provider.
Contract...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Paxlovid Drug Therapy - Finland Tender

The HUS GROUP, a Government sector organization in Finland, has announced a new tender for Paxlovid Drug Therapy. This tender is published on FinlandTenders under FIT Ref No: 93602169 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-12-18.

The estimated tender value is EUR 2000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.